Who Paid My Doc
Howard Finestone
Nuclear Radiology Brooklyn, NY Medical Doctor
NPI 1235236746 CMS profile 740331
Maimonides Med Ctr 4802 10Th Ave, Brooklyn, NY 11219
General payments
$21
Research payments
$0
Ownership & investment interest
$0
Through program year 2024, Howard Finestone of Brooklyn, NY is reported in the CMS Open Payments database as having received $21 across 1 general payment and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 4th percentile of Nuclear Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2024 | General | $21 | 1 |
Beside peers
- Howard Finestone
- Nuclear Radiology median
- Middle half of Nuclear Radiology
- National median
In program year 2025, general payments to Howard Finestone were reported at $0. Among 103 Nuclear Radiology profiles paid that year, the median was $145 and the middle half received between $47 and $1,684.
Show as a table
| Year | Howard Finestone | Nuclear Radiology median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $0 | $136 | $49–$543 | $163 |
| 2020 | $0 | $102 | $32–$2,014 | $114 |
| 2021 | $0 | $72 | $25–$381 | $132 |
| 2022 | $0 | $69 | $25–$202 | $149 |
| 2023 | $0 | $89 | $28–$281 | $160 |
| 2024 | $21 | $133 | $40–$829 | $164 |
| 2025 | $0 | $145 | $47–$1,684 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 23 billing codesPaid by Medicare
$38,409
Medicare patients
1,669
Services billed
4,641
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| Diabetes | 75% | |
| High blood pressure | 75% | |
| Arthritis | 70% | |
| Ischemic heart disease | 69% | |
| Heart failure | 68% | |
| Atrial fibrillation | 53% | |
| Chronic kidney disease | 52% | |
| Alzheimer's or dementia | 42% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Nuclear Radiology in New York
Tony Abraham
Nuclear Radiology · Port Jefferson Station, NY
Dinko Franceschi
Nuclear Radiology · Stony Brook, NY
Paul Lang
Nuclear Radiology · Garden City, NY
Belur Chandramouly
Nuclear Radiology · Brooklyn, NY
Lijun Weng
Nuclear Radiology · Brooklyn, NY
Maria Tomas
Nuclear Radiology · New Hyde Park, NY
Related records
Nuclear Radiology in New York
Practitioners in the same specialty and state, ranked by reported value.
All Nuclear Radiology
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.